Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 127
10
Diseases
22
Unique genes
0.169
Avg. similarity score
Coronal craniosynostosis
Most-connected disease (6 links)
Disease
Searched: duane retraction syndrome 2
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
duane retraction syndrome 2
Coronal craniosynostosis
Brachycephaly
Robinow syndrome
Sweeney-cox syndrome
TWIST1-related craniosynostosis
TCF12-related craniosynostosis
Extraskeletal myxoid chondrosarcoma
Binocular vision disease
Omodysplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Coronal craniosynostosis | 6 | 6 | 3 |
| Brachycephaly | 5 | 5 | 10 |
| Robinow syndrome | 5 | 5 | 8 |
| Sweeney-cox syndrome | 4 | 4 | 1 |
| TWIST1-related craniosynostosis | 4 | 4 | 1 |
| TCF12-related craniosynostosis | 3 | 3 | 1 |
| Extraskeletal myxoid chondrosarcoma | 2 | 2 | 5 |
| Binocular vision disease | 1 | 1 | 1 |
| Omodysplasia | 1 | 1 | 2 |
| duane retraction syndrome 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TWIST1 | 5 / 10 | Brachycephaly, Coronal craniosynostosis, Robinow syndrome, Sweeney-cox syndrome and 1 more |
| TCF12 | 4 / 10 | Brachycephaly, Coronal craniosynostosis, Extraskeletal myxoid chondrosarcoma, TCF12-related craniosynostosis |
| CHN1 | 2 / 10 | duane retraction syndrome 2, Robinow syndrome |
| FGFR3 | 2 / 10 | Brachycephaly, Coronal craniosynostosis |
| FZD2 | 2 / 10 | Omodysplasia, Robinow syndrome |
| RPS23 | 2 / 10 | Binocular vision disease, Brachycephaly |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | Reactome | 4 / 30 | 72.8× | 2.24e-7 | 1.41e-5 ✓ sig. |
| Wnt signaling pathway | KEGG | 6 / 174 | 18.8× | 5.22e-7 | 2.95e-5 ✓ sig. |
| WNT5:FZD7-mediated leishmania damping | Reactome | 3 / 12 | 136× | 1.16e-6 | 5.93e-5 ✓ sig. |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | Reactome | 3 / 13 | 126× | 1.51e-6 | 7.48e-5 ✓ sig. |
| PCP/CE pathway | Reactome | 3 / 18 | 91.0× | 4.28e-6 | 1.79e-4 ✓ sig. |
| Basal cell carcinoma | KEGG | 4 / 63 | 34.7× | 4.68e-6 | 1.93e-4 ✓ sig. |
| Signaling pathways regulating pluripotency of stem cells | KEGG | 5 / 144 | 19.0× | 5.16e-6 | 2.08e-4 ✓ sig. |
| Breast cancer | KEGG | 5 / 148 | 18.4× | 5.91e-6 | 2.31e-4 ✓ sig. |
| Gastric cancer | KEGG | 5 / 150 | 18.2× | 6.31e-6 | 2.43e-4 ✓ sig. |
| mTOR signaling pathway | KEGG | 5 / 158 | 17.3× | 8.13e-6 | 3.01e-4 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 5 / 170 | 16.1× | 1.16e-5 | 4.01e-4 ✓ sig. |
| Melanogenesis | KEGG | 4 / 101 | 21.6× | 3.07e-5 | 8.93e-4 ✓ sig. |
| Pathways in cancer | KEGG | 7 / 533 | 7.2× | 3.10e-5 | 9.03e-4 ✓ sig. |
| WNT mediated activation of DVL | Reactome | 2 / 9 | 121× | 1.14e-4 | 2.58e-3 ✓ sig. |
| Cushing syndrome | KEGG | 4 / 155 | 14.1× | 1.63e-4 | 3.42e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Wnt signaling pathway | GO:0016055 | 7 / 232 | 25.6× | 6.04e-9 | 1.10e-6 ✓ sig. |
| non-canonical Wnt signaling pathway | GO:0035567 | 4 / 33 | 103× | 5.76e-8 | 7.67e-6 ✓ sig. |
| Wnt signaling pathway, planar cell polarity pathway | GO:0060071 | 4 / 34 | 99.9× | 6.53e-8 | 8.54e-6 ✓ sig. |
| positive regulation of neuron projection arborization | GO:0150012 | 3 / 8 | 319× | 7.90e-8 | 1.01e-5 ✓ sig. |
| canonical Wnt signaling pathway | GO:0060070 | 5 / 105 | 40.4× | 1.24e-7 | 1.48e-5 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 8 / 778 | 8.7× | 1.66e-6 | 1.28e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 9 / 1,208 | 6.3× | 4.41e-6 | 2.79e-4 ✓ sig. |
| cochlea morphogenesis | GO:0090103 | 3 / 28 | 91.0× | 4.55e-6 | 2.86e-4 ✓ sig. |
| convergent extension involved in organogenesis | GO:0060029 | 2 / 5 | 340× | 1.32e-5 | 6.71e-4 ✓ sig. |
| embryonic digit morphogenesis | GO:0042733 | 3 / 57 | 44.7× | 3.98e-5 | 1.56e-3 ✓ sig. |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 3 / 60 | 42.5× | 4.64e-5 | 1.76e-3 ✓ sig. |
| inner ear morphogenesis | GO:0042472 | 3 / 65 | 39.2× | 5.90e-5 | 2.10e-3 ✓ sig. |
| genitalia development | GO:0048806 | 2 / 10 | 170× | 5.92e-5 | 2.11e-3 ✓ sig. |
| presynapse assembly | GO:0099054 | 2 / 14 | 121× | 1.19e-4 | 3.55e-3 ✓ sig. |
| regulation of protein localization | GO:0032880 | 3 / 89 | 28.6× | 1.51e-4 | 4.24e-3 ✓ sig. |